By integrating QSAR models, multi-model fusion techniques, and the PSO algorithm, this study aims to achieve multi-objective optimization of anti-breast cancer compounds, enhancing their biological activity against ERα while ensuring excellent ADMET properties. This evidence concerns the gene ESR1 and breast carcinoma.